The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Budzinskaya M.V.

Krasnov Research Institute of Eye Diseases

Plyukhova A.A.

Krasnov Research Institute of Eye Diseases

Differential diagnosis of various types of fluids on the eye fundus in patients with age-related macular degeneration

Authors:

Budzinskaya M.V., Plyukhova A.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2020;136(4): 354‑358

Read: 3388 times


To cite this article:

Budzinskaya MV, Plyukhova AA. Differential diagnosis of various types of fluids on the eye fundus in patients with age-related macular degeneration. Russian Annals of Ophthalmology. 2020;136(4):354‑358. (In Russ.)
https://doi.org/10.17116/oftalma2020136042354

Recommended articles:
Neuroprotective therapy for age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):152-158
Choroidal neovascularization asso­ciated with choroidal nevi. Russian Annals of Ophthalmology. 2025;(1):104-112

References:

  1. Lim L, Mitchell P, Seddon J, Holz F, Wong T. Age-related macular degeneration. Lancet. 2012;379(9827):1728-1738. https://doi.org/10.1016/S0140-6736(12)60282-7
  2. Ferris F III, Fine S, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Archives of Ophthalmology. 1984; 102(11):1640-1642.
  3. Bailey S, Thaware O, Wang J, Hagag A, Zhang X, Flaxel C, Lauer A, Hwang T, Lin P, Huang D, Jia Y. Detection of Non-exudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using Optical Coherence Tomography Angiography. Ophthalmology Retina. 2019;3(8):629-636.  https://doi.org/10.1016/j.oret.2019.03.008
  4. Mokwa N, Ristau T, Keane P, Kirchhof B, Sadda S, Liakopoulos S Grading of age- related macular degeneration: comparison between color fundus photography, fluorescein angiography, and spectral domain optical coherence tomography. Journal of Ophthalmology. 2013;2013:1-6.  https://doi.org/10.1155/2013/385915
  5. Lek J, Caruso E, Baglin E, Sharangan P, Hodgson L, Harper C, Rosenfeld P, Luu C, Guymer R. Interpretation of Subretinal Fluid Using OCT in Intermediate Age-Related Macular Degeneration. Ophthalmology Retina. 2(8):792-802.  https://doi.org/10.1016/j.oret.2018.01.005
  6. Sheremet NL, Mikaelian AA, Andreev AYu, Kiselev SL. Possibilities of treating retinal diseases in patients with damaged retinal pigment epithelium. Vestnik oftal’mologii. 2019;135(5-2):226-334. (In Russ). https://doi.org/10.17116/oftalma2019135052226
  7. Sikorski B, Bukowska D, Kaluzny J,Szkulmowski M, Kowalczyk A, Woltkowski M. Drusen with accompanying fluid underneath the sensory retina. Ophthalmology. 2011;118(1):82-92.  https://doi.org/10.1016/j.ophtha.2010.04.017
  8. Cohen S, Dubois L, Nghiem-Buffet S, Ayrault S, Fajnkuchen F, Guiberteau B, Delahaye-Mazza C, Quentel G, Tadayoni R. Retinal pseudocysts in age-related geographic atrophy. American Journal of Ophthalmology. 2010; 150(2):211-217.  https://doi.org/10.1016/j.ajo.2010.02.019
  9. Powner M, Gillies M, Tretiach M, Scott A, Guymer R, Hageman G, Fruttiger M. Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 2010;117(12):2407-2416. https://doi.org/10.1016/j.ophtha.2010.04.001
  10. Leuschen J, Schuman S, Winter K, McCall M, Wong W, Chew E, Hwang T, Srivastava S, Sarin N, Clemons T, Harrington M, Toth C. Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration. Ophthalmology. 2013;120(1):140-150.  https://doi.org/10.1016/j.ophtha.2012.07.004
  11. Gianniou C, Dirani A, Jang L, Mantel I. Refractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal ranizubimab: Functional and structural outcome. Retina. 2015;35(6): 1195-1201. https://doi.org/10.1097/IAE.0000000000000465
  12. Querques G, Avellis F, Querques L, Bandello F, Souied E. Age-related macular degeneration. Clinical Ophthalmology. 2011;5:593‐601.  https://doi.org/10.2147/OPTH.S10161
  13. Schmidt-Erfurth U, Sebastian M. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Progress in Retinal and Eye Research. 2016;50:1-24.  https://doi.org/10.1016/j.preteyeres.2015.07.007
  14. Roisman L, Zhang Q, Wang R. Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology. 2016;123(6):1309-1319. https://doi.org/10.1016/j.ophtha.2016.01.044
  15. Steinberg J, Göbel A, Thiele S, Fleckenstein M, Holz F, Schmitz-Valckenberg S. Development of intraretinal cystoid lesions in eyes with intermediate age-related macular degeneration. Retina (Philadelphia, Pa.). 2016;36(8): 1548-1556. https://doi.org/10.1097/IAE.0000000000000951
  16. Waldstein S, Wright J, Warburton J, Margaron P, Simader C, Schmidt-Erfurth U. Predictive value of retinal morphology for visual acuity outcomes of different ranibizumab treatment regimens for neovascular AMD. Ophthalmology. 2016;123(1):60-69.  https://doi.org/10.1016/j.ophtha.2015.09.013
  17. Petrachkov D. The new complex method of treatment central retinal vein and branch of retinal vein occlusion. Billuten Sibirskoi medizini. 2008;7(1):99-101. (In Russ.).
  18. Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ; Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Macular morphology and visual acuity in the second year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2016;123(4):865-75.  https://doi.org/10.1016/j.ophtha.2015.12.002

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.